[Pathogenesis and prevention diabetes mellitus vascular complications].
Balabolkin
M I
MI
Kreminskaia
V M
VM
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control*; D004075:Diglycerides / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism; D004781:Environmental Exposure / Q000009:adverse effects; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D018384:Oxidative Stress; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*
D000975:Antioxidants; D016861:Cyclooxygenase Inhibitors; D004075:Diglycerides; D017127:Glycation End Products, Advanced; D011448:Prostaglandin Antagonists